Paper32648895
Base excision repair and its implications to cancer therapy.
Grundy GJ and 1 other. Essays Biochem, 2020. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Base excision repair and its implications to cancer therapy. Papers, record 32648895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32648895
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Repair | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Oxidative Stress |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 32725152 | Correction: Base excision repair and its implications to cancer therapy. | https://conductscience.org/library/papers/32725152 |
Source PubMed
References108
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28254358 | Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase. | DNA Repair (Amst) | 2017 | https://conductscience.org/library/papers/28254358 | PubMed |
| 2 | 19773431 | Identification of a small molecule inhibitor of the human DNA repair enzyme polynucleotide kinase/phosphatase. | Cancer Res | 2009 | https://conductscience.org/library/papers/19773431 | PubMed |
| 3 | 29078112 | Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor. | DNA Repair (Amst) | 2017 | https://conductscience.org/library/papers/29078112 | PubMed |
| 4 | 27530147 | PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2B(Glu2). | Nat Commun | 2016 | https://conductscience.org/library/papers/27530147 | PubMed |
| 5 | 32192183 | Thiopurine Derivative-Induced Fpg/Nei DNA Glycosylase Inhibition: Structural, Dynamic and Functional Insights. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32192183 | PubMed |
| 6 | 29113422 | Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers. | Oncotarget | 2017 | https://conductscience.org/library/papers/29113422 | PubMed |
| 7 | 21211721 | PARP-3 and APLF function together to accelerate nonhomologous end-joining. | Mol Cell | 2011 | https://conductscience.org/library/papers/21211721 | PubMed |
| 8 | 28459532 | Synergistic Effects of an Irreversible DNA Polymerase Inhibitor and DNA Damaging Agents on HeLa Cells. | ACS Chem Biol | 2017 | https://conductscience.org/library/papers/28459532 | PubMed |
| 9 | 15260972 | AP endonuclease-independent DNA base excision repair in human cells. | Mol Cell | 2004 | https://conductscience.org/library/papers/15260972 | PubMed |
| 10 | 15831793 | APE1-dependent repair of DNA single-strand breaks containing 3'-end 8-oxoguanine. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15831793 | PubMed |
| 11 | 22455312 | Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors. | J Med Chem | 2012 | https://conductscience.org/library/papers/22455312 | PubMed |
| 12 | 31611371 | The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31611371 | PubMed |
| 13 | 23054206 | A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. | Invest New Drugs | 2013 | https://conductscience.org/library/papers/23054206 | PubMed |
| 14 | 24349107 | Inhibition of DNA glycosylases via small molecule purine analogs. | PLoS One | 2013 | https://conductscience.org/library/papers/24349107 | PubMed |
| 15 | 21390132 | Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. | Nature | 2011 | https://conductscience.org/library/papers/21390132 | PubMed |
| 16 | 18954712 | Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential. | Int J Radiat Oncol Biol Phys | 2008 | https://conductscience.org/library/papers/18954712 | PubMed |
| 17 | 23118055 | Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Cancer Res | 2012 | https://conductscience.org/library/papers/23118055 | PubMed |
| 18 | 24356813 | Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. | Mol Cancer Ther | 2014 | https://conductscience.org/library/papers/24356813 | PubMed |
| 19 | 9295348 | Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9295348 | PubMed |
| 20 | 21390131 | DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair. | Nature | 2011 | https://conductscience.org/library/papers/21390131 | PubMed |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42539504 | Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates. | Front Oncol | 2026 | https://conductscience.org/library/papers/42539504 | PubMed |
| 42501138 | DNA Repair, Epigenetic Dysregulation, and Cytokine Network Crosstalk in Head and Neck Cancer: Emerging Therapeutic Opportunities and Clinical Trials. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42501138 | PubMed |
| 42490199 | DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street? | Oncologist | 2026 | https://conductscience.org/library/papers/42490199 | PubMed |
| 42316271 | Changes in active DNA demethylation pathway components during neoadjuvant chemotherapy and their prognostic significance in breast cancer. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42316271 | PubMed |
| 42305202 | A SMUG1 Inhibitor Modulates the Excision of Pyrimidine DNA Damage. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42305202 | PubMed |
| 41958649 | P62 in colorectal cancer: from inflammation suppression to cancer promotion. | Front Immunol | 2026 | https://conductscience.org/library/papers/41958649 | PubMed |
| 41930181 | Roles of ADP-Ribosyltransferases in Cancer. | Oncol Res | 2026 | https://conductscience.org/library/papers/41930181 | PubMed |
| 41897348 | Hypomorphic Protein Expression of DNA Polymerase Beta in PolβL301R-V303R/L301R-V303R Knock-In Transgenic Mice Does Not Impact Global DNA Methylation Levels in the Midbrain. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897348 | PubMed |
| 41809040 | miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma. | iScience | 2026 | https://conductscience.org/library/papers/41809040 | PubMed |
| 41480637 | Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferons. | NAR Cancer | 2025 | https://conductscience.org/library/papers/41480637 | PubMed |
| 41474538 | Identification of prognostic genes associated with mitochondria and macrophage polarization in prostate adenocarcinoma based on transcriptome and Mendelian randomization analysis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41474538 | PubMed |
| 41473689 | Translational Aspects of DNA Damage Repair in Optimizing Cancer Chemotherapy. | Adv Genet (Hoboken) | 2025 | https://conductscience.org/library/papers/41473689 | PubMed |
| 41303849 | Cellular and Molecular Mechanisms of Oxidative DNA Damage and Repair. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41303849 | PubMed |
| 41287826 | Radiation-Induced Biological Effects: Molecular and Cellular Mechanism, and Applications to Radiation/Nuclear Emergency and Cancer Therapy. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41287826 | PubMed |
| 41188452 | KDM6A deficiency promotes tumor progression and resistance to cabozantinib treatment in clear cell renal cell carcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/41188452 | PubMed |
| 41155399 | DNA Damage and Repair in Pancreatic Cancer-The Latest Findings. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155399 | PubMed |
| 40841665 | Tumor irradiation induced immunogenic response: the impact of DNA damage induction and misrepair. | Radiat Oncol | 2025 | https://conductscience.org/library/papers/40841665 | PubMed |
| 40761744 | Research progress on the role of the NEIL family in cancer. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40761744 | PubMed |
| 40723396 | Epigenetic Drivers of Chemoresistance in Nucleobase and Nucleoside Analog Therapies. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40723396 | PubMed |
| 40440929 | Development and characterization of a novel NEIL1 nanobody. | DNA Repair (Amst) | 2025 | https://conductscience.org/library/papers/40440929 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32648895
GET https://conductscience.org/api/papers/v1/32648895/references?page=2